Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 7
1982 5
1983 4
1984 4
1985 12
1986 6
1987 3
1988 7
1989 15
1990 9
1991 12
1992 18
1993 15
1994 24
1995 21
1996 23
1997 32
1998 35
1999 29
2000 48
2001 34
2002 48
2003 34
2004 33
2005 43
2006 33
2007 31
2008 34
2009 40
2010 39
2011 31
2012 33
2013 47
2014 27
2015 47
2016 35
2017 40
2018 33
2019 38
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

977 results
Results by year
Filters applied: . Clear all
Page 1
Management of post-transplant lymphoproliferative disorders.
DeStefano CB, Desai SH, Shenoy AG, Catlett JP. DeStefano CB, et al. Br J Haematol. 2018 Aug;182(3):330-343. doi: 10.1111/bjh.15263. Epub 2018 May 9. Br J Haematol. 2018. PMID: 29741774 Review.
The post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious complications of bone marrow and solid organ transplants. ...This paper will provide a comprehensive review of PTLD following sol …
The post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious com …
Post-transplant lymphoproliferative disorders.
Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Dharnidharka VR, et al. Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88. Nat Rev Dis Primers. 2016. PMID: 27189056 Review.
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the t …
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Bar
Post-transplant lymphoproliferative disorders.
Singavi AK, Harrington AM, Fenske TS. Singavi AK, et al. Cancer Treat Res. 2015;165:305-27. doi: 10.1007/978-3-319-13150-4_13. Cancer Treat Res. 2015. PMID: 25655616 Review.
Post-transplant lymphoproliferative disorders (PTLD) are a serious complication after solid organ or allogeneic hematopoietic stem cell transplantation and include a range of diseases from benign proliferations to malignant lymphomas. Risk factors for …
Post-transplant lymphoproliferative disorders (PTLD) are a serious complication after solid organ or allogeneic hematopoietic …
How I treat posttransplant lymphoproliferative disorders.
Dierickx D, Tousseyn T, Gheysens O. Dierickx D, et al. Blood. 2015 Nov 12;126(20):2274-83. doi: 10.1182/blood-2015-05-615872. Epub 2015 Sep 17. Blood. 2015. PMID: 26384356
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disorder arising after solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). Iatrogenically impaired immune surveillance and Epstein-Barr virus (EBV) …
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disorder arising after solid organ transplant (SOT) …
Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P, Shiels MS, Lynch CF, Engels EA. Mahale P, et al. Am J Transplant. 2018 Feb;18(2):453-461. doi: 10.1111/ajt.14465. Epub 2017 Sep 2. Am J Transplant. 2018. PMID: 28805292 Free PMC article.
Using data from the US transplant registry linked with 17 cancer registries (1987-2014), we studied PCNSL and systemic non-Hodgkin lymphoma (NHL) in 288 029 solid organ transplant recipients. ...PCNSL incidence was higher in Asians/Pacific Islanders th …
Using data from the US transplant registry linked with 17 cancer registries (1987-2014), we studied PCNSL and systemic non-Hodgkin …
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
Al-Mansour Z, Nelson BP, Evens AM. Al-Mansour Z, et al. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5. Curr Hematol Malig Rep. 2013. PMID: 23737188 Free PMC article. Review.
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. ...Most PTLD cases are B cell …
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferati …
Comprehensive review of post-organ transplant hematologic cancers.
Dharnidharka VR. Dharnidharka VR. Am J Transplant. 2018 Mar;18(3):537-549. doi: 10.1111/ajt.14603. Epub 2018 Jan 10. Am J Transplant. 2018. PMID: 29178667 Free article. Review.
In this part of a continuing series on cancers posttransplantation, this review focuses on the hematologic cancers after solid organ transplantation. ...The oncogenic Epstein-Barr virus is a key pathogenic driver in many PTLD cases, through known and u …
In this part of a continuing series on cancers posttransplantation, this review focuses on the hematologic cancers after solid organ
Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types.
Aguilera N, Gru AA. Aguilera N, et al. Semin Diagn Pathol. 2018 Jul;35(4):236-246. doi: 10.1053/j.semdp.2018.02.001. Epub 2018 Mar 3. Semin Diagn Pathol. 2018. PMID: 29615296 Review.
Post-transplant lymphoproliferative disorders (PTLD) are a known risk for both solid organ transplant and stem cell transplant recipients. Overall transplant recipients have a six fold increase in risk for developing any kind of non-Hodgkin l
Post-transplant lymphoproliferative disorders (PTLD) are a known risk for both solid organ transplant and stem cell …
Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA. Fellner MD, et al. Rev Argent Microbiol. 2016 Apr-Jun;48(2):110-8. doi: 10.1016/j.ram.2016.02.006. Epub 2016 May 4. Rev Argent Microbiol. 2016. PMID: 27157146 Free article.
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. ...Transversal study: paired peripheral blood mononuclear …
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consens …
Mutational landscape of B-cell post-transplant lymphoproliferative disorders.
Menter T, Juskevicius D, Alikian M, Steiger J, Dirnhofer S, Tzankov A, Naresh KN. Menter T, et al. Br J Haematol. 2017 Jul;178(1):48-56. doi: 10.1111/bjh.14633. Epub 2017 Apr 17. Br J Haematol. 2017. PMID: 28419429 Clinical Trial.
It is currently unclear whether post-transplant diffuse large B-cell lymphomas (PT-DLBCL) display a similar genomic landscape as DLBCL in immunocompetent patients (IC-DLBCL). ...In comparison to IC-DLBCLs, Epstein-Barr virus (EBV)(+) PT-DLBCL had fewer …
It is currently unclear whether post-transplant diffuse large B-cell lymphomas (PT-DLBCL) display a similar genomic landscape …
977 results
Jump to page
Feedback